期刊文献+

肥厚型心肌病肌钙蛋白T基因突变的研究 被引量:5

A novel missense mutation. K124N, in the troponin T gene of Chinese populations with hypertrophic cardiomyopathy
原文传递
导出
摘要 目的调查中国人群肥厚型心肌病(HCM)患者基因突变的发生情况并对基因型与临床表型之间的关系进行分析。方法对71例HCM先证者及100名正常对照的聚合酶链反应扩增产物行单链构象多态性分析,于肌钙蛋白T(TNNT2)基因第8、9、10、11、16外显子范围内寻找突变位点,并了解基因型明确的HCM患者的临床特点。结果 在1例患者TNNT2基因的第9外显子上发现了一个新的错义突变位点124A>C(K124N)。由于在100名正常对照中未见该错义突变,故我们认为此突变位点为该患者的致病基因位点。该患者38岁起出现临床症状,超声表现为室间隔中度肥厚,家族中无心源性猝死发作史。结论肌钙蛋白T的尾端对于其连接功能起着至关重要的作用,该区域的基因突变可导致肥厚型心肌病的发生。证实了该病具有异质性遗传的特点。 Objective To study the cardiac troponin T (TNNT2) gene mutation in Chinese patients with hypertrophic cardiomyopathy ( HCM ) and to analyze the correlation between the genotype and phenotype. Methods Specimens of peripheral blood were collected from 71 unrelated Chinese probands with HCM, aged 40 ±18. The genome DNA was extracted. Single-strand conformation polymorphism gel analysis of the polymerase chain reaction-amplified products was conducted to search for mutations in the exons 8 , 9, 10, 11, and 16 of the TNNT2 gene. Relevant clinical data were collected. One hundred normal persons, aged 44 ± 14, were used as controls. Results A missense mutation, K124N, in the exon 9 of the TNNT2 gene was identified in a 41-year-old female patient with HCM and failed to be detected in the 100 normal controls, which suggested the disease-causing mutation. The patient began to have the symptoms of chest distress and palpitation since the age of 38, presented moderate hypertrophy of the intraventricular septum, and did not have a family history of sudden cardiac death. Conclusion A novel missense mutation of troponin T gene has been identified. Mutation in tail part of cardiac troponin T, essential for it's binding function, causes the disease of HCM. Correlative analysis confirms the genetic heterogeneity of the disease.
出处 《中华医学杂志》 CAS CSCD 北大核心 2004年第16期1340-1343,共4页 National Medical Journal of China
基金 山东省科委基金资助项目(981216509)
关键词 肥厚型心肌病 肌钙蛋白T 基因突变 肥大性 聚合酶链反应 HCM Cardiomyopathy, hypertrophic Troponin T Mutation Genes
  • 相关文献

参考文献12

  • 1Maron BJ, Gardin JM, Flack JM, et al. Prevalence of hypertrophic cardiomyopothy in a general population of young adults. Circulation,1995,92:785-789.
  • 2Marian AJ, Robert R. The molecular genetic basis for hypertrophic cardiomyopathy. J Mol Cell Cardiol,2001,33 :655-670.
  • 3Watkins H, Mckenna WJ, Thiefelder L, et al. The role of cardiac troponin T and α-tropomyosin. N Engl J Med,1995 ,332 :1058-1064.
  • 4van Driest SL, Ellsworth EG, Ommen SR, et al. Prevalence and spectrum of thin filament mutations in an outpatient referral population with hypertrophic cardiomyopathy. Circulation, 2003,108:445451.
  • 5Maron B J, McKenna WJ, Danielson GK, et al. American college of cardiology/European society of cardiology clinical expert consensus document on hypertrophic cardiomyopathy. European Heart J, 2003,24:1965-1991.
  • 6Palm T, Graboski S. Disease-causing mutation in cardiac troponin T:identification of a critical tropomyosin-binding region. Biophys J,2001, 81:2827-2837.
  • 7Tardiff JC, Facton SM, Tompkins BD, et al. A Truncated cardiac troponin T molecule in transgenetic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy. J Clin Invest,1998,101:2800-2811.
  • 8Ho C ,Lever H, DeSanctis R, et al. Homozygous mutation in cardiac troponin T: implications for hypertrophic cardiomyopathy.Circulation ,2000,102:1950-1955.
  • 9Crilley JG, Boehm EA, Blair E, et al. Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy. J Am Coll Cardiol,2003 ,41:1762-1782.
  • 10Varnava AM, Elliott PM, Baboonian C, et al. Hypertrophic cardiomyopathy -histopathological features of sudden cardiac death in cardiac troponin T disease. Circulation ,2001,104:1380-1384.

同被引文献64

  • 1刘文玲,谢文丽,胡大一,朱天刚,李运田,孙艺红,李翠兰,李蕾,李田昌,边红,仝其广,杨松娜,范瑞云,崔炜.十个汉族家族性肥厚型心肌病MYH7、MYBPC3和TNNT2基因筛查结果及相应的临床特征[J].中华心血管病杂志,2006,34(3):202-207. 被引量:25
  • 2Millat G, Bouvagnet P, Chevalier P, et al. Prevalence and spectrum of mutations in a cohort of 192 unrelated patients with hypertrophic cardiomyopathy[J]. Eur J Meal Genet, 2010, 53(5): 261-7.
  • 3Colombo MG, Botto N, Vittorini S, et al. Clinical utility of genetic tests for inherited hypertrophic and dilated cardiomyopathies [J]. Cardiovascular Ultrasound, 2008: 62.
  • 4Maron BJ. The 2009 international hypertrophic cardiomyopathy summit[J]. Am J Cardiol, 2010, 105(8): 1164-8.
  • 5Heradien M, Revera M, van der Merwe L, et al.Abnormal blood pressure response to exercise occurs more frequently in hypertrophic cardiomyopathy patients with the R92W troponin T mutation than in those with myosin mutations [J]. Heart Rhythm, 2009, 6(11): S18-24.
  • 6Sirenko SG, Potter JD, Knollmann BC. Differential effect of troponin T mutations on the inotropic responsiveness of mouse hearts-role of myofi lament Ca2 + sensitivity increase [J], 2006: 201-13.
  • 7Fiset C, Giles WR. Cardiac troponin T mutations promote life-threatening arrhythmias [J]. J Clin Invest, 2008, 118(12): 3845-7. doi: 10.1172/JCI37787. Epub 2008 Nov 20.
  • 8Bos M J, Ommen SR, Ackerman MJ, et al. Genetics of hypertrophic cardiomyopathy: one, two, or more diseases[J]? Curr Opin Cardiol, 2007, 22: 193-9.
  • 9Sirenko SG, Potter JD, Knollmann BC. Differential effect of troponin T mutations on the inotropic responsiveness of mouse hearts - role of myofilament Ca2+ sensitivity increase[J]. J Physiol, 2006: 201-13.
  • 10Song L, Zou YB, Wang JZ, et al. Mutations profile in Chinese patients with hypertrophic cardiomyopathy [J]. Clin Chim Acta, 2005, 351: 209-16.

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部